Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Clin Pharmacol Ther. 2013 Jun 11;94(4):525–532. doi: 10.1038/clpt.2013.119

Table 2.

Changes in Individual Metabolite Levels Post-Aspirin

Metabolite HMDB ID Before Aspirin After Aspirin Change P-value
Salicylic acid HMDB01895 0.1±0.4 1.8±0.8 <1×10-3
Salicyluric acid HMDB00840 0.5±0.2 1.4±0.9 <1×10-3
Azelaic acid HMDB00784 1.3±0.9 0.6±0.4 <1×10-3
D-Ribose HMDB00283 1.3±1.1 0.6±0.7 <1×10-3
L-Aspartic acid HMDB00191 1.2±0.3 0.7±0.2 <1×10-3
Inosine* HMDB00195 0.7±0.7 1.2±0.8 <1×10-3
Guanosine* HMDB00133 0.7±0.5 1.2±0.7 <1×10-3
Adenosine-5-monophosphate* HMDB00045 0.8±0.2 1.1±0.6 <1×10-3
Oleic acid HMDB00207 1.1±0.5 0.8±0.6 <1×10-3
Palmitoleic acid HMDB03229 1.1±0.7 0.8±0.8 <1×10-3
Linoleic acid HMDB00673 1.1±0.4 0.8±0.6 <1×10-3
Hypoxanthine* HMDB00157 1.1±0.6 0.8±0.5 <1×10-3
Shikimic acid HMDB03070 1.1±0.4 0.8±0.3 <1×10-3
Xanthine* HMDB00292 1.1±0.4 0.8±0.4 <1×10-3
Arachidonic acid HMDB01043 1±0.3 0.9±0.4 0.002
3-Phosphoglyceric acid HMDB00807 1.1±0.4 0.8±0.2 0.003
Adenosine* HMDB00050 0.8±0.7 1.1±0.9 0.004
2,5-Furandicarboxylic acid HMDB04812 0.9±0.4 1±0.5 0.008

Data represent standardized mean ± SD of metabolite levels for all individuals (N=76), divided by mean metabolite level detected in this study. P-values calculated using LMM. Only metabolites with p<0.05 and q<0.1 are displayed.

*

Indicates member of Purine Metabolism pathway.